GASTROINTESTINAL (GI) TRACT POORLY DIFFERENTIATED ENDOCRINE CARCINOMA (PDEC): MAMMALIAN TARGET OF RAPAMYCIN (MTOR) EXPRESSION ANALYSIS

被引:0
|
作者
Catena, Laura
Milione, Massimo [1 ,2 ]
Carbone, Antonino [1 ,2 ]
Platania, Marco
Ducceschi, Monika
机构
[1] Fdn IRCCS Ist Nazl Tumori, Med Oncol Unit 2, Milan, Italy
[2] Fdn IRCCS Ist Nazl Tumori, Dept Pathol, Milan, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [1] mTOR expression in gastrointestinal (GI) tract poorly differentiated endocrine carcinoma (PDEC)
    Catena, L.
    Carbone, A.
    Milione, M.
    Platania, M.
    Ducceschi, M.
    Dominioni, F.
    Di Guardo, L.
    Buzzoni, R.
    Formisano, B.
    Bajetta, E.
    EJC SUPPLEMENTS, 2009, 7 (02): : 145 - 146
  • [2] Mammalian Target of Rapamycin (mTOR) Expression Analysis and Therapeutic Approach in Lung and Gastroenteropancreatic Poorly Differentiated Endocrine Carcinoma (PDEC)
    Catena, L.
    Milione, M.
    Pusceddu, S.
    Ducceschi, M.
    Avarino, M.
    Valente, M.
    Colonna, V
    Barone, G.
    Bajetta, E.
    NEUROENDOCRINOLOGY, 2010, 92 (01) : 4 - 4
  • [3] MTOR EXPRESSION ANALYSIS IN LUNG AND GASTROENTEROPANCREATIC POORLY DIFFERENTIATED ENDOCRINE CARCINOMA (PDEC)
    Catena, L.
    Bajetta, E.
    Milione, M.
    Valente, M.
    Pusceddu, S.
    Ducceschi, M.
    Avarino, C.
    Pietrantonio, F.
    Biondani, P.
    Colonna, V.
    ANNALS OF ONCOLOGY, 2010, 21 : 265 - 265
  • [4] Mammalian target of rapamycin expression in poorly differentiated endocrine carcinoma: clinical and therapeutic future challenges
    Catena, Laura
    Bajetta, Emilio
    Milione, Massimo
    Ducceschi, Monika
    Valente, Monica
    Dominoni, Francesca
    Colonna, Valentina
    TARGETED ONCOLOGY, 2011, 6 (02) : 65 - 68
  • [5] Mammalian target of rapamycin expression in poorly differentiated endocrine carcinoma: clinical and therapeutic future challenges
    Laura Catena
    Emilio Bajetta
    Massimo Milione
    Monika Ducceschi
    Monica Valente
    Francesca Dominoni
    Valentina Colonna
    Targeted Oncology, 2011, 6 : 65 - 68
  • [6] Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract
    Pizzi, S
    Azzoni, C
    Bassi, D
    Bottarelli, L
    Milione, M
    Bordi, C
    CANCER, 2003, 98 (06) : 1273 - 1282
  • [7] Expression and activity analysis of mammalian target of rapamycin (mTOR) complexes in human lymphoma cells
    Nagy, N.
    Mark, A.
    Paku, S.
    Nemeth, Z. S.
    Buthi, N.
    Kopper, L.
    Sebestyen, A.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S839 - S839
  • [8] Regulation of Gene Expression in Hepatic Cells by the Mammalian Target of Rapamycin (mTOR)
    Jimenez, Rosa H.
    Lee, Ju-Seog
    Francesconi, Mirko
    Castellani, Gastone
    Neretti, Nicola
    Sanders, Jennifer A.
    Sedivy, John
    Gruppuso, Philip A.
    PLOS ONE, 2010, 5 (02):
  • [9] Expression of an activated mammalian target of rapamycin (mTOR) in gastroenteropancreatic neuroendocrine tumors
    Takashi Shida
    Takashi Kishimoto
    Mitsuko Furuya
    Takashi Nikaido
    Keiji Koda
    Shigetsugu Takano
    Fumio Kimura
    Hiroaki Shimizu
    Hiroyuki Yoshidome
    Masayuki Ohtsuka
    Tohru Tanizawa
    Yukio Nakatani
    Masaru Miyazaki
    Cancer Chemotherapy and Pharmacology, 2010, 65 : 889 - 893
  • [10] Expression of an activated mammalian target of rapamycin (mTOR) in gastroenteropancreatic neuroendocrine tumors
    Shida, Takashi
    Kishimoto, Takashi
    Furuya, Mitsuko
    Nikaido, Takashi
    Koda, Keiji
    Takano, Shigetsugu
    Kimura, Fumio
    Shimizu, Hiroaki
    Yoshidome, Hiroyuki
    Ohtsuka, Masayuki
    Tanizawa, Tohru
    Nakatani, Yukio
    Miyazaki, Masaru
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (05) : 889 - 893